Elevated serum immunoglobulin g4 levels in patients with graves' disease and their clinical implications

Thyroid

Volumn 24, Issue 4, 2014, Pages 736-743

  Takeshima, Ken ^a   Inaba, Hidefumi ^a   Furukawa, Yasushi ^a   Nishi, Masahiro ^a   Yamaoka, Hiroyuki ^a   Miyamoto, Waka ^a   Ota, Takayuki ^a   Doi, Asako ^a   Kawashima, Hiromichi ^a   Ariyasu, Hiroyuki ^a   Wakasaki, Hisao ^a   Furuta, Hiroto ^a   Nakao, Taisei ^a   Sasaki, Hideyuki ^a   Akamizu, Takashi ^a  

^a WAKAYAMA MEDICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; IMMUNOGLOBULIN G4; LEVOTHYROXINE; PROPYLTHIOURACIL; THIAMAZOLE; ANTITHYROID AGENT; IMMUNOGLOBULIN G; THYROID STIMULATING IMMUNOGLOBULIN; THYROXINE;

ADOLESCENT; ADULT; AGED; ARTICLE; BLOOD LEVEL; CLINICAL FEATURE; CORRELATION ANALYSIS; DISEASE ASSOCIATION; FEMALE; GRAVES DISEASE; HUMAN; HYPOTHYROIDISM; IMAGE ANALYSIS; IMMUNOGLOBULIN G4 RELATED DISEASE; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSPECTIVE STUDY; ULTRASOUND; BLOOD; CLASSIFICATION; IMMUNOLOGY; MIDDLE AGED; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; ANTITHYROID AGENTS; FEMALE; GRAVES DISEASE; HUMANS; IMMUNOGLOBULIN G; IMMUNOGLOBULINS, THYROID-STIMULATING; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; THYROXINE; YOUNG ADULT;

EID: 84898416491     PISSN: 10507256     EISSN: 15579077     Source Type: Journal    
DOI: 10.1089/thy.2013.0448     Document Type: Article

References (28)

1. Hamano H, Kawa S, Horiuchi A, Unno H, Furuya N, Akamatsu T, Fukushima M, Nikaido T, Nakayama K, Usuda N, Kiyosawa K 2001 High serum IgG4 concentrations in patients with sclerosing pancreatitis. N Engl J Med 344:732-738
2. Stone JH, Zen Y, Deshpande V 2012 IgG4-related disease. N Engl J Med 366:539-551
3. Li Y, Nishihara E, Hirokawa M, Taniguchi E, Miyauchi A, Kakudo K 2010 Distinct clinical, serological, and sonographic characteristics of Hashimoto's thyroiditis based with and without IgG4-positive plasma cells. J Clin Endocrinol Metab 95:1309-1317
4. Dahlgren M, Khosroshahi A, Nielsen GP, Deshpande V, Stone JH 2010 Riedel's thyroiditis and multifocal fibrosclerosis are part of the IgG4-related systemic disease spectrum. Arthritis Care Res (Hoboken) 62:1312-1318
5. Hennessey JV 2011 Clinical review: Riedel's thyroiditis: A clinical review. J Clin Endocrinol Metab 96:3031-3041
6. Watanabe T, Maruyama M, Ito T, Fujinaga Y, Ozaki Y, Maruyama M, Kodama R, Muraki T, Hamano H, Arakura N, Kadoya M, Suzuki S, Komatsu M, Shimojo H, Notohara K, Uchida M, Kawa S 2013 Clinical features of a new disease concept, IgG4-related thyroiditis. Scand J Rheumatol 42:325-330
7. Umehara H, Okazaki K, Masaki Y, Kawano M, Yamamoto M, Saeki T, Matsui S, Yoshino T, Nakamura S, Kawa S, Hamano H, Kamisawa T, Shimosegawa T, Shimatsu A, Nakamura S, Ito T, Notohara K, Sumida T, Tanaka Y, Mimori T, Chiba T, Mishima M, Hibi T, Tsubouchi H, Inui K, Ohara H 2012 Comprehensive diagnostic criteria for IgG4-related disease (IgG4-RD), 2011. Mod Rheumatol 22:21-30
8. Masaki Y, Kurose N, Yamamoto M, Takahashi H, Saeki T, Azumi A, Nakada S, Matsui S, Origuchi T, Nishiyama S, Yamada K, Kawano M, Hirabayashi A, Fujikawa K, Sugiura T, Horikoshi M, Umeda N, Minato H, Nakamura T, Iwao H, Nakajima A, Miki M, Sakai T, Sawaki T, Kawanami T, Fujita Y, Tanaka M, Fukushima T, Eguchi K, Sugai S, Umehara H 2012 Cutoff values of serum IgG4 and histopathological IgG4 + plasma cells for diagnosis of patients with IgG4-related disease. Int J Rheumatol 2012: 580814
9. Mourits MP, Prummel MF, Wiersinga WM, Koornneef L 1997 Clinical activity score as a guide in the management of patients with Graves' ophthalmopathy. Clin Endocrinol (Oxf) 47:9-14
10. Werner SC 1977 Modification of the classification of the eye changes of Graves' disease: Recommendations of the Ad Hoc Committee of the American Thyroid Association. J Clin Endocrinol Metab 44:203-204
11. Yoshida A, Adachi T, Noguchi T, Urabe K, Onoyama S, Okamura Y, Shigemasa C, Abe K, Mashiba H 1985 Echographic findings and histological feature of the thyroid: A reverse relationship between the level of echoamplitude and lymphocytic infiltration. Endocrinol Jpn 32:681-690
12. Yamamoto M, Nishimoto N, Tabeya T, Naishiro Y, Ishigami K, Shimizu Y, Yajima H, Matsui M, Suzuki C, Takahashi H, Imai K, Shinomura Y 2012 [Usefulness of measuring serum IgG4 level as diagnostic and treatment marker in IgG4-related disease]. Nihon Rinsho Meneki Gakkai Kaishi 35:30-37. (In Japanese.)
13. DeGroot LJ, Quintans J 1989 The causes of autoimmune thyroid disease. Endocr Rev 10:537-562
14. Schauer U, Stemberg F, Rieger CH, Borte M, Schubert S, Riedel F, Herz U, Renz H, Wick M, Carr-Smith HD, Bradwell AR, Herzog W 2003 IgG subclass concentrations in certified reference material 470 and reference values for children and adults determined with the binding site reagents. Clin Chem 49:1924-1929
15. Parkes AB, McLachlan SM, Bird P, Rees Smith B 1984 The distribution of microsomal and thyroglobulin antibody activity among the IgG subclasses. Clin Exp Immunol 57:239-243
16. Davies TF, Weber CM, Wallack P, Platzer M 1986 Restricted heterogeneity and T cell dependence of human thyroid autoantibody immunoglobulin G subclasses. J Clin Endocrinol Metab 62:945-949
17. Caturegli P, Kuppers RC, Mariotti S, Burek CL, Pinchera A, Ladenson PW, Rose NR 1994 IgG subclass distribution of thyroglobulin antibodies in patients with thyroid disease. Clin Exp Immunol 98:464-469
18. Weetman AP, Fung HY, Richards CJ, McGregor AM 1990 IgG subclass distribution and relative functional affinity of thyroid microsomal antibodies in postpartum thyroiditis. Eur J Clin Invest 20:133-136
19. Latrofa F, Chazenbalk GD, Pichurin P, Chen CR, McLachlan SM, Rapoport B 2004 Affinity-enrichment of thyrotropin receptor autoantibodies from Graves' patients and normal individuals provides insight into their properties and possible origin from natural antibodies. J Clin Endocrinol Metab 89:4734-4745
20. Sanders J, Evans M, Premawardhana LD, Depraetere H, Jeffreys J, Richards T, Furmaniak J, Rees Smith B 2003 Human monoclonal thyroid stimulating autoantibody. Lancet 362:126-128
21. Nishihara E, Hirokawa M, Takamura Y, Ito M, Nakamura H, Amino N, Miyauchi A 2013 IgG4 thyroiditis in a Graves' disease patient with large goiter developing hypothyroidism. Thyroid 23:1496-1497
22. Kawashima ST, Tagami T, Nakao K, Nanba K, Tamanaha T, Usui T, Naruse M, Minamiguchi S, Mori Y, Tsuji J, Tanaka I, Shimatsu A 2014 Serum levels of IgG and IgG4 in Hashimoto thyroiditis. Endocrine 45:236-243
23. Aalberse RC, Schuurman J 2002 IgG4 breaking the rules. Immunology 105:9-19
24. McLachlan SM, Bahn R, Rapoport B 1992 Endocrine ophthalmopathy: A re-evaluation of the association with thyroid autoantibodies. Autoimmunity 14:143-148
25. Guo J, Jaume JC, Rapoport B, McLachlan SM 1997 Recombinant thyroid peroxidase-specific Fab converted to immunoglobulin G (IgG) molecules: Evidence for thyroid cell damage by IgG1, but not IgG4, autoantibodies. J Clin Endocrinol Metab 82:925-931
26. Marcocci C, Vitti P, Cetani F, Catalano F, Concetti R, Pinchera A 1991 Thyroid ultrasonography helps to identify patients with diffuse lymphocytic thyroiditis who are prone to develop hypothyroidism. J Clin Endocrinol Metab 72:209-213
27. Fatourechi V, McConahey WM, Woolner LB 1971 Hyperthyroidism associated with histologic Hashimoto's thyroiditis. Mayo Clin Proc 46:682-689
28. Fonseca V, Thomas M, Havard CW 1988 Hashitoxicosis and autoantibody interference with thyroid function tests. J R Soc Med 81:546-547.